Michael R Mcalevey
CIK 1907875 · View on SEC EDGAR ↗
First SEC filing: Feb. 1, 2022 · Latest: Feb. 1, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | HCA | S | 1,694 | $533.37 | $903,529 | 8,853 Direct | -16.06% | Disposed | -23.1% (price as of 2026-08-20) |
| Nov. 5, 2025 | HCA | S | 3,892 | $473.79 | $1,843,991 | 3,487 Direct | -52.74% | Disposed | -13.4% (price as of 2026-08-20) |
| April 29, 2022 | HCA | P | 1,110 | $218.56 | $242,602 | 1,110 Direct | — | Acquired | 87.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | HCA | Stock Appreciation Right | Common Stock (5,000) | $236.61 | Jan. 28, 2032 | 5,000 | Disposed |
| Jan. 29, 2026 | HCA | Stock Appreciation Right | Common Stock (8,067) | $482.53 | Jan. 29, 2036 | 8,067 | Acquired |
| Nov. 3, 2025 | HCA | Stock Appreciation Right | Common Stock (13,170) | $236.61 | Jan. 28, 2032 | 13,170 | Disposed |
| Jan. 28, 2025 | HCA | Stock Appreciation Right | Common Stock (11,171) | $328.70 | Jan. 28, 2035 | 11,171 | Acquired |
| April 29, 2024 | HCA | Stock Appreciation Right | Common Stock (2,274) | $311.42 | April 29, 2034 | 2,274 | Acquired |
| Jan. 31, 2024 | HCA | Stock Appreciation Right | Common Stock (11,005) | $304.90 | Jan. 31, 2034 | 11,005 | Acquired |
| Jan. 28, 2024 | HCA | Restricted Stock Units | Common Stock (1,940) | — | Jan. 28, 2032 | 1,940 | Disposed |
| Jan. 30, 2023 | HCA | Stock Appreciation Right | Common Stock (12,630) | $253.30 | Jan. 30, 2033 | 12,630 | Acquired |
| Jan. 28, 2023 | HCA | Restricted Stock Units | Common Stock (1,940) | — | Jan. 28, 2032 | 1,940 | Disposed |
| Jan. 28, 2022 | HCA | Restricted Stock Units | Common Stock (3,880) | — | — | 3,880 | Acquired |
| Jan. 28, 2022 | HCA | Stock Appreciation Right | Common Stock (13,170) | $236.61 | Jan. 28, 2032 | 13,170 | Acquired |
| Jan. 28, 2022 | HCA | Stock Appreciation Right | Common Stock (13,860) | $236.61 | Jan. 28, 2032 | 13,860 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 1, 2022 | HCA | Common Stock | 26 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1,012,688 | — | — | — | $1,986,638 | — | $167,624 | $5,710,335 |
| 2024 | $981,254 | — | — | — | $1,847,906 | — | $126,340 | $5,738,785 |
| 2022 | $860,536 | $1,600,000 | — | — | $162,291 | — | $78,294 | $6,465,633 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.